Co-Authors
This is a "connection" page, showing publications co-authored by CARLA DAVIS and AIKATERINI ANAGNOSTOU.
Connection Strength
1.453
-
Diagnosis and management of shrimp allergy. Front Allergy. 2024; 5:1456999.
Score: 0.244
-
Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy. PLoS One. 2022; 17(5):e0264674.
Score: 0.206
-
Maximum Dose Food Challenges Reveal Transient Sustained Unresponsiveness in Peanut Oral Immunotherapy (POIMD Study). J Allergy Clin Immunol Pract. 2022 02; 10(2):566-576.e6.
Score: 0.200
-
Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy. Ann Allergy Asthma Immunol. 2020 08; 125(2):196-201.e1.
Score: 0.178
-
Quality of life in food allergic children: Results from 174 quality-of-life patient questionnaires. Ann Allergy Asthma Immunol. 2020 04; 124(4):379-384.
Score: 0.175
-
Emerging triggers of food protein-induced enterocolitis syndrome: Lessons from a pediatric cohort of 74 children in the United States. Ann Allergy Asthma Immunol. 2019 04; 122(4):407-411.
Score: 0.164
-
Fecal microbiome signatures are different in food-allergic children compared to siblings and healthy children. Pediatr Allergy Immunol. 2018 08; 29(5):545-554.
Score: 0.156
-
Skin testing with different food formulations in pediatric patients with eosinophilic esophagitis. Pediatr Allergy Immunol. 2020 04; 31(3):329-332.
Score: 0.044
-
Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here? J Allergy Clin Immunol. 2020 04; 145(4):1153-1156.
Score: 0.043
-
ICER report for peanut OIT comes up short. Ann Allergy Asthma Immunol. 2019 11; 123(5):430-432.
Score: 0.043